 overview venous thromboembolism prophylaxis symposium risk factors problems venous thromboembolism surgical patients patients total hip replacement importance venous thromboembolism prophylaxis theoretical analysis venous thromboembolism patients hip replacement lives effective discussion pharmacology low-molecular-weight heparin LMWH review role venous thromboembolism prophylaxis discussants favorable experiences LMWH incidence venous thromboembolism patients hip replacement LMWH incidence venous thromboembolism patients hip replacement increase blood loss effectiveness safety substantiated LMWH preferred agent venous thromboembolism prophylaxis